Marc Tessier-Lavigne, Ph.D.

Marc Tessier-Lavigne, Ph.D.

DirectoratDenali Therapeutics· In proxies 2023–2025

Marc Tessier-Lavigne, Ph.D. sits on 4 public boards.

Experience

  1. Denali TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -28%
  2. Agios PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  3. Juno TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  4. PfizerPublic company
    • Director? – PresentNo stock prices for these years
  5. Regeneron PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?